NCT06456463 2026-03-09
TRILLIUM
Stemline Therapeutics, Inc.
Phase 2 Recruiting
Clinical Trials
5 trialsNCT05442216 2026-01-23
TAGALONG
Hoosier Cancer Research Network
Phase 2 Recruiting
NCT07007052 2025-11-26
TAGVEN
French Innovative Leukemia Organisation
Phase 2 Not yet recruiting
NCT04342962 2025-01-30
Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Terminated
NCT04317781 2024-07-31
Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 2 Terminated